Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point?
Goodarzi, Mark O
Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point? [electronic resource] - JAMA Nov 2008 - 2051-3 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1538-3598
10.1001/jama.2008.510 doi
Cardiovascular Diseases--etiology
Diabetes Mellitus, Type 2--complications
Diabetic Angiopathies--etiology
Humans
Hypoglycemic Agents--therapeutic use
Insulin Resistance
Glucose lowering to control macrovascular disease in type 2 diabetes: treating the wrong surrogate end point? [electronic resource] - JAMA Nov 2008 - 2051-3 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1538-3598
10.1001/jama.2008.510 doi
Cardiovascular Diseases--etiology
Diabetes Mellitus, Type 2--complications
Diabetic Angiopathies--etiology
Humans
Hypoglycemic Agents--therapeutic use
Insulin Resistance